Harvard Men's Health Watch

New drugs make treating hepatitis C faster and easier

Chronic infection with the hepatitis C virus (HCV) can lead to liver disease and cancer in a minority of infected people. New drug regimens reduce treatment duration and side effects.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In